Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)
Agency: National Institutes of Health
Assistance Listings
- 93.855 -- Allergy and Infectious Diseases Research
- 93.394 -- Cancer Detection and Diagnosis Research
- 93.397 -- Cancer Centers Support Grants
- 93.121 -- Oral Diseases and Disorders Research
- 93.279 -- Drug Abuse and Addiction Research Programs
- 93.846 -- Arthritis, Musculoskeletal and Skin Diseases Research
- 93.350 -- National Center for Advancing Translational Sciences
- 93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders
- 93.084 -- Prevention of Disease, Disability, and Death by Infectious Diseases
- 93.113 -- Environmental Health
- 93.866 -- Aging Research
- 93.399 -- Cancer Control
- 93.213 -- Research and Training in Complementary and Integrative Health
- 93.395 -- Cancer Treatment Research
- 93.867 -- Vision Research
- 93.351 -- Research Infrastructure Programs
- 93.847 -- Diabetes, Digestive, and Kidney Diseases Extramural Research
- 93.396 -- Cancer Biology Research
- 93.398 -- Cancer Research Manpower
- 93.393 -- Cancer Cause and Prevention Research
- 93.242 -- Mental Health Research Grants
- 93.173 -- Research Related to Deafness and Communication Disorders
- 93.172 -- Human Genome Research
- 93.273 -- Alcohol Research Programs
- 93.262 -- Occupational Safety and Health Program
Archived opportunityLast Updated: May 13, 2026
View version history on Grants.gov
Description
This funding opportunity announcement (FOA) seeks to develop and nurture a national innovation ecosystem that builds upon biomedical research to develop technologies, products, and services that benefit society. Toward meeting this objective, the I-Corps program is being offered. The I-Corps at NIH program is focused on educating researchers and technologists on how to translate technologies from the lab into the marketplace. Under this FOA, participating NIH and CDC Institutes and Centers will continue providing administrative supplement awards to currently-funded SBIR and STTR Phase I grantees....
The program is designed to provide three-member project teams with access to instruction and mentoring in order to accelerate the translation of technologies currently being developed with NIH and Centers for Disease Control and Prevention (CDC) SBIR and STTR funding. It is anticipated that outcomes for the I-Corps teams participating in this program will include significantly refined commercialization plans and well-informed pivots in their overall commercialization strategies. Prospective applicants are strongly encouraged to contact NIH or CDC Scientific/Research staff for more information about the program before applying.
Eligibility
Eligible applicants
Business
- Small businesses
Additional information
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Grantor contact information
Description
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Documents
No documents are currently available.
Link to additional information
Archived: March 4, 2021
Award
$1,200,000
Program Funding
24
Expected awards
$--
Award Minimum
$--
Award Maximum
Funding opportunity number:
PA-19-029
Cost sharing or matching requirement:
No
Funding instrument type:
Grant
Opportunity Category:
Discretionary
Opportunity Category Explanation:
--
Category of Funding Activity:
Environment
Education
Food and nutrition
Health
Category Explanation:
--
History
Version:
2
Posted date:
October 17, 2018
Archive date:
March 4, 2021
